Rize Oncology Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	May '25 May 22, 2025	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Market Capitalization	12	13	-	-	-	-
Enterprise Value	11	13	-	-	-	-
Last Close Price	0.16	0.16	-	-	-	-
PB Ratio	53.98	28.98	-	-	-	-
P/TBV Ratio	53.98	28.98	-	-	-	-
Net Debt / Equity Ratio	-0.29	-0.78	-1.05	-0.99	-0.97	-1.14
Net Debt / EBITDA Ratio	-	0.35	-	-	-	-
Quick Ratio	1.24	3.95	13.98	35.33	20.54	0.84
Current Ratio	2.24	4.53	14.35	36.56	22.24	1.74
Return on Equity (ROE)	-200.59%	-160.97%	-44.40%	-42.64%	-170.34%	-4122.37%
Return on Assets (ROA)	-106.62%	-88.96%	-28.28%	-27.84%	-92.74%	-492.06%
Return on Capital Employed (ROCE)	-543.20%	-281.70%	-53.10%	-54.50%	-92.50%	-1041.10%
Earnings Yield	-10.05%	-9.69%	-	-	-	-
Buyback Yield / Dilution	-64.81%	-96.12%	16.52%	-7.75%	-20.45%	-32.93%